Biomaterials are eco-friendly substances that have significant use in the medical history for treatment or diagnostic purposes. These materials are also used to treat, repair or replace a tissue function of the body without any damage to other organs or side effects. This is completely different from the biological material and the selection of material should suitable for the system as it may biocompatible with the other even though it is suitable for one application excellently. Biomaterials can be obtained from natural resources and also can synthesized in the laboratories.
Global Biomaterials Market Size and CAGR – (2019 - 2024)
MarketDataForecast predicts that the global market size for Biomaterials will reach 96.6 Billion USD in 2019 and 185.9 billion by 2024, growing at a CAGR of 14.5% during the forecast period.
Drivers
Increasing investments in the medical sector by both the private and public sector is leading with the highest shares of the market. Rise in the incidences of cardiovascular diseases globally is fueling the demand of the market. Growing prevalence for medical implants is accelerating the growth of the market.
Challenges
However, the lack of skilled persons in handling the substances effectively is slightly restricting the demand of the biomaterials market. Stringent rules and regulations by the government may impact negatively on the growth of the market.
Opportunities
Rise in the capital income in both developed and developing countries is the main attribute to create chances for the growth of the market further. Increasing expenditure on healthcare is likely to bolster the demand of the market. Growth opportunities for the market lie in the growing demand for non-invasive surgeries.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 – 2024 |
|
Segments Analysed |
By Material Type (metallic, ceramic, polymers and natural), Application (cardiovascular, orthopedic, dental, plastic surgeries, wound healing, tissue engineering, neurological disorders and ophthalmology) and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) |
|
Countries Scope |
United States and Canada, UK, Spain, Germany, Italy, France, China, India, Japan, South Korea, Australia, New Zealand, Brazil, Argentina, Mexico, Middle East and Africa |
|
Leading Companies Analysed |
Royal DSM, Zimmer Biomet Holdings, Inc., Evonik Industries AG, Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc. |
Metallic material type is holding the highest shares of the market
Based on the material type, the market is segmented into metallic, ceramic, polymers and natural. Metallic material type is accounted in leading with the highest shares of the market. Increasing the use of biomaterials in plastic surgeries is magnifying the demand of the market.
Cardiovascular application is ruling with the highest shares of the market
By application, the market is bifurcated into cardiovascular, orthopedic, dental, plastic surgeries, wound healing, tissue engineering, neurological disorders, and ophthalmology. Cardiovascular application is dominating shares of the market. Rise in the support from the government by changing schemes in favor of the common people is escalating the growth of the market.
North America is gaining traction in leading dominant shares of the market
Regionally, the global biomaterials market is segmented into North America, Asia Pacific, Europe, and the Middle East and Africa. North America is accounted for largest shares of the market by owing to emergence of the latest technological developments and launch of new techniques. Also, increasing disposable income in urban areas is lavishing the demand of the market.
The Asia Pacific is following North America is dominating the shares of the market. Increasing geriatric population is broadening the shares of the market in this region. In addition, growing incidences of bone fractures and demand for surgeries is boosting up the growth of the market. India and China are major countries contributing the highest shares for the market in the Asia Pacific.
Europe is growing at a faster rate from the past decade and is also expected to have a tremendous growth rate in the coming years. Increasing demand for the utilization of environment-friendly substances in the medical sector is straightly elevating the growth rate of the market. The Middle East and Africa is inclined to have prominent shares in coming years with the rise in awareness over the manufacturing of the latest devices with advanced technology.
Top Companies leading the Global Biomaterials Market profiled in this research report are
Some of the noteworthy players in the world market are Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).
Browse Regional Market Reports of Biomaterials:
North America Biomaterials Market
Asia Pacific Biomaterials Market
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Material type
5.1.1 Ceramic
5.1.2 Metallic
5.1.3 Polymer
5.1.4 Natural
5.2 By Application
5.2.1 Orthopaedic
5.2.2 Dental
5.2.3 Cardiovascular
5.2.4 Plastic surgery
5.2.5 Wound healing
5.2.6 Ophthalmology
5.2.7 Tissue engineering
5.2.8 Neurological
5.2.9 Others
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Collagen Matrix, Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zimmer Biomet Holdings, Inc
8.3 Evonik Industries AG
8.4 Wright Medical Technology, Inc.,
8.5 Corbion N.V
8.6 Berkeley Advanced Biomaterials
8.7 Bayer AG
8.8 Carpenter Technology Corporation
8.9 Covalon Technologies Ltd.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
